[1]
|
Pisetsky, D.S., Erlandsson-Harris, H. and Andersson, U. (2008) High-Mobility Group Box Protein 1 (HMGB1): An Alarmin Mediating the Pathogenesis of Rheumatic Disease. Arthritis Research & Therapy, 10, 1-10.
http://dx.doi.org/10.1186/ar2440
|
[2]
|
Yu, M., Wang, H.C., Ding, A.H., Douglas, T., Golenbock, E.L., Czura, C.J., et al. (2006) HMGB1 Signals through Toll-Like Receptor (TLR)4 and TLR2. Shock, 26, 174-179. http://dx.doi.org/10.1097/01.shk.0000225404.51320.82
|
[3]
|
Rahman, A. and Isenberg, D.A. (2008) Systemic Lupus Erythematosus. The New England Journal of Medicine, 358, 929-939. http://dx.doi.org/10.1056/NEJMra071297
|
[4]
|
Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheumatology, 40, 1725. http://dx.doi.org/10.1002/art.1780400928
|
[5]
|
Zickert, A., Palmblad, K., Sundelin, B., Chavan, S., Tracey, K.J., Bruchfeld, A., et al. (2012) Renal Expression and Serum Levels of High Mobility Group Box 1 Protein in Lupus Nephritis. Arthritis Research & Therapy, 14, 1-10.
http://dx.doi.org/10.1186/ar3747
|
[6]
|
Isenberg, D.A., Rahman, A., Allen, E., Farewell, V., Akil, M., Bruce, I.N., et al. (2005) BILAG 2004. Development and Initial Validation of an Updated Version of the British Isles Lupus Assessment Group’s Disease Activity Index for Patients with Systemic Lupus Erythematosus. Rheumatology (Oxford), 44, 902-906.
http://dx.doi.org/10.1093/rheumatology/keh624
|
[7]
|
Yee, C.S., Farewell, V., Isenberg, D.A., Griffiths, B., The, L.S., Bruce, I.N., et al. (2009) The BILAG-2004 Index Is Sensitive to Change for Assessment of SLE Disease Activity. Rheumatology (Oxford), 48, 691-695.
http://dx.doi.org/10.1093/rheumatology/kep064
|
[8]
|
Abdulahad, D.A., Westra, J., Bijzet, J., Limburg, P.C., Kallenberg, C.G. and Bijl, M. (2011) High Mobility Group Box 1 (HMGB1) and Anti-HMGB1 Antibodies and Their Relation to Disease Characteristics in Systemic Lupus Erythematosus. Arthritis Research Therapy, 13, R71. http://dx.doi.org/10.1186/ar3332
|
[9]
|
Kruse, K., Janko, C., Urbonaviciute, V., Mierke, C.T., Winkler, T.H., Voll, R.E., et al. (2010) Inefficient Clearance of Dying Cells in Patients with SLE: Anti-dsDNA Autoantibodies, MFG-E8, HMGB-1 and Other Players. Apoptosis, 15, 1098-1113. http://dx.doi.org/10.1007/s10495-010-0478-8
|
[10]
|
Pullerits, R., Jonsson, I.-M., Verdrengh, M., Bokarewa, M., Andersson, U., Erlandsson-Harris, H., et al. (2003) High Mobility Group Box Chromosomal Protein 1, a DNA Binding Cytokine, Induces Arthritis. Arthritis Rheumatology, 48, 1693-1700. http://dx.doi.org/10.1002/art.11028
|
[11]
|
Yoshizaki, A., Komura, K., Iwata, Y., Ogawa, F., Hara, T. and Muroi, E. (2009) Clinical Significance of Serum HMGB1-1 and Srage Level in Systemic Sclerosis: Association with Disease Severity. Journal of Clinical Immunology, 29, 180-189. http://dx.doi.org/10.1007/s10875-008-9252-x
|
[12]
|
Urbonaviciute, V., Fürnrohr, B.G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., et al. (2008) Induction of Inflammatory and Immune Responses by HMGB1-Nucleosome Complexes: Implications for the Pathogenesis of SLE. Journal of Experimental Medicine, 205, 3007-3018. http://dx.doi.org/10.1084/jem.20081165
|
[13]
|
Bruchfeld, A., Wendt, M., Bratt, J., Qureshi, A.R., Chavan, S., Tracey, K.J., et al. (2011) High-Mobility Group Box-1 Protein (HMGB1) Is Increased in Antineutrophilic Cytoplasmatic Antibody (ANCA)-Associated Vasculitis with Renal Manifestations. Molecular Medicine, 17, 29-35. http://dx.doi.org/10.2119/molmed.2010.00132
|
[14]
|
Kruse, K., Janko, C., Urbonaviciute, V., Mierke, C.T., Winkler, T.H., Voll, R.E., et al. (2010) Inefficient Clearance of Dying Cells In Patients with SLE: Anti-dsDNA Autoantibodies, MFG-E8, HMGB-1 and Other Players. Apoptosis, 15, 1098-1113. http://dx.doi.org/10.1007/s10495-010-0478-8
|
[15]
|
Friggeri, A., Banerjee, S., Biswas, S., Freitas, A., Liu, G. and Bierhaus, A. (2011) Participation of the Receptor for Advanced Glycation End Products in Efferocytosis. Journal of Immunology, 186, 6191-6198.
http://dx.doi.org/10.4049/jimmunol.1004134
|